- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0012351

Apley Pharma Private Limited
About Apley Pharma Private Limited
Data last updated:
Apley Pharma Private Limited is a private limited company based in Hardwar, Uttarakhand, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 19 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74999UR2019PTC009931. Its GSTIN is 05AASCA4184A1ZT (Uttarakhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Varun Verma and Rahul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hardwar, Uttarakhand.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.37 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹8,842 (net margin -0.4%) and EBITDA of -₹8,842 (EBITDA margin -0.4%).
Apley Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0012351).
Company details
Recognitions & Rankings of Apley Pharma
Contact details
Apley Pharma Private Limited's registered office is in Hardwar, Uttarakhand. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 20 Kh No – 495/1, Om Vihar Colony Village Jamalpur Kalan, Hardwar, Uttarakhand, India – 249407
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Apley Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Apley Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Apley Pharma Private Limited, buy the company report.
Financials of Apley Pharma Private Limited
FY 2025 filings availableApley Pharma Private Limited reported revenue of ₹24.37 Lakh (up 286% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 286% in the latest year. EBITDA fell 284% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹8,842 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8,842 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.4% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apley Pharma Private Limited, buy the company report.
Board of directors of Apley Pharma Private Limited
Apley Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varun Verma | Director | 26 Dec 2020 | 5 Years 10 Months | Current |
| Rahul Also directs: Teaspoon Pharmaceuticals (India) Private Limited | Director | 19 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Apley Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biocuris Pharmaceuticals Private Limited | ₹24.38 Lakh (FY 2023) | Mumbai, Maharashtra, India | ||||
| Mahashakti Alloys Private Limited | ₹24.38 Lakh (FY 2024) | 5949.0% | Bareilly, Uttar Pradesh, India | |||
| Tugania Exports Private Limited | ₹24.38 Lakh (FY 2017) | -33.0% | New Delhi, Delhi, India | |||
| Unifrin Multinational Private Limited | ₹24.37 Lakh (FY 2024) | -32.0% | Chennai, Tamil Nadu, India | |||
| Terradevo International Private Limited | ₹24.37 Lakh (FY 2023) | -81.0% | Bhavnagar, Gujarat, India | |||
| Apley Pharma Private Limitedthis company | ₹24.37 Lakh (FY 2024) | -₹8,842 | -0.4% | 286.0% | Hardwar, Uttarakhand, India | |
| JMS Softnet Private Limited | ₹24.37 Lakh (FY 2019) | -17.0% | New Delhi, Delhi, India | |||
| Rashi Agricultural Farms Private Limited | ₹24.37 Lakh (FY 2016) | 70.0% | Navi Mumbai, Maharashtra, India | |||
| Ranbhumi Commosales Private Limited | ₹24.37 Lakh (FY 2017) | -27.0% | Kolkata, West Bengal, India | |||
| Himayam Publishers Private Limited | ₹24.36 Lakh (FY 2025) | -22.0% | Chennai, Tamil Nadu, India | |||
| Gobamboos Private Limited | ₹24.36 Lakh (FY 2023) | 41.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Apley Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Apley Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apley Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Apley Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AASCA4184A1ZT | Uttarakhand | Active | 23 Nov 2020 |
To see the full GST registrations and return filing status of Apley Pharma Private Limited, buy the company report.
Recent activity
Apley Pharma Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Rupali Suri ceased to be Director on 12 Apr 2025.
Frequently asked questions
Apley Pharma is an active private limited company based in Hardwar, Uttarakhand, India. The company works in other services, within the business services industry. It was incorporated on 19 June 2019 (7+ years old) and is registered under CIN U74999UR2019PTC009931.
Apley Pharma has 2 current directors:
- Varun Verma - Director
- Rahul - Director
The latest financial statements of Apley Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Apley Pharma is 05AASCA4184A1ZT, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Apley Pharma is U74999UR2019PTC009931. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apley Pharma was incorporated on 19 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Apley Pharma by revenue are Biocuris Pharmaceuticals Private Limited, Mahashakti Alloys Private Limited, Tugania Exports Private Limited, Unifrin Multinational Private Limited, Terradevo International Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Rupali Suri ceased to be Director on 12 Apr 2025. Jyoti Tuli ceased to be Director on 28 Dec 2020. Varun Verma was appointed as Director on 26 Dec 2020. Apley Pharma has 4 board changes on record in total.
Yes, Apley Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0012351).
The registered office of Apley Pharma is at Plot No. 20 Kh No – 4951, Om Vihar Colony Village Jamalpur Kalan, Hardwar, Uttarakhand, India – 249407.
Apley Pharma operates in the business services industry, in the other services segment.

